Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03341728 · ClinicalTrials.gov registry record · NA

The Sensorimotor Locus of Balance Control in Elderly Gait

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
14
Enrollment target

NCT03341728 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03341728, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

The aging population is at an exceptionally high risk of debilitating falls, contributing significantly to reduced independence and quality of life. It remains extremely challenging to screen for falls risk, and programs designed to mitigate falls risk have only modestly influenced the sizeable portion of the aging population experiencing one or more falls annually. Balance control in standing and walking depends on integrating reliable sensory feedback and on planning and executing appropriate motor responses. Walking balance control is especially dynamic, requiring active and coordinated adjustments in posture (i.e., trunk stabilization) and foot placement from step to step. Accordingly, using a custom, immersive virtual environment, the investigators have shown that sensory (i.e., optical flow) perturbations, especially when applied during walking, elicit strong and persistent motor responses to preserve balance. Exciting pilot data suggest that these motor responses are remarkably more prevalent in old age, presumably governed by an increased reliance on vision for balance control. Additional pilot data suggest that prolonged exposure to these perturbations may effectively condition successful balance control strategies. Founded on these recent discoveries, and leveraging the increase reliance on vision for balance control in old age, the investigators stand at the forefront of a potentially transformative new approach for more effectively identifying and mitigating age-related falls risk. The investigator's overarching hypothesis is that optical flow perturbations, particularly when applied during walking, can effectively identify balance deficits due to aging and falls history and can subsequently condition the neuromechanics of successful balance control via training.

Interventions

  • BEHAVIORAL Optical flow perturbations
  • BEHAVIORAL Normal walking

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2017-10-30
Est. Completion 2018-07-25
Phase NA

What the Registry Record Tells You About NCT03341728

The ClinicalTrials.gov registry entry for NCT03341728 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Optical flow perturbations is the first listed.

NCT03341728 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03341728 about?

NCT03341728 is a clinical study titled "The Sensorimotor Locus of Balance Control in Elderly Gait". The aging population is at an exceptionally high risk of debilitating falls, contributing significantly to reduced independence and quality of life. It remains extremely challenging to screen for falls risk, and programs designed to mitigate falls risk have only modestly influenced the sizeable port...

What is the current status of trial NCT03341728?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2017-10-30. Estimated completion is 2018-07-25.

What interventions are being tested in trial NCT03341728?

The interventions under investigation include: Optical flow perturbations (BEHAVIORAL), Normal walking (BEHAVIORAL).

Who is sponsoring clinical trial NCT03341728?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.